Marqeta (MQ) has become a focus for investors after a recent earnings report in which both revenue and EBITDA came in ahead of analyst forecasts, yet the stock dropped sharply afterward.

The recent post earnings drop fits into a wider picture where Marqeta’s 1 day share price return of 0.50% and 30 day share price return of 2.86% contrast with a year to date share price decline of 14.87% and a 1 year total shareholder return decline of 32.36%. This suggests momentum has faded despite short term lifts around results.

If this kind of volatility has you looking beyond Marqeta, it could be a good moment to widen your watchlist with 20 top founder-led companies

So with Marqeta beating on revenue and EBITDA yet trading around $3.95 and sitting below analyst price targets, is the recent weakness pointing to an undervalued stock, or is the market already pricing in its future growth?

Most Popular Narrative: 24.5% Undervalued

With Marqeta shares last closing at $3.95 against a narrative fair value of $5.24, the current pricing gap has caught a lot of attention.

The completed TransactPay acquisition gives Marqeta full program management and EMI capabilities in Europe, enabling entry into larger enterprise opportunities, uniformity of service across North America and Europe, and easier multi-market expansion for clients. This unlocks new revenue streams, increases take rates, and improves earnings scalability.

Want to see what kind of revenue mix and margin profile that expansion is built on? The narrative leans on steady volume growth, rising profitability, and a richer earnings multiple to justify that fair value.

Result: Fair Value of $5.24 (UNDERVALUED)

However, Marqeta’s dependence on a small number of large customers, along with rising competitive and regulatory pressure, could quickly challenge the optimistic upside that investors are focusing on.

Another View: Marqeta Looks Expensive On Sales

The narrative fair value suggests Marqeta is 24.5% undervalued, but the market is telling a different story on revenue. At a P/S of 2.6x versus 2.1x for the US Diversified Financial industry and 0.9x for peers, and above a fair ratio of 2.3x, the stock carries valuation risk rather than a clear discount. Which signal do you weigh more heavily?

For a closer look at how this pricing compares with fundamentals, take a moment to review See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

Given the mix of optimism and concern around Marqeta, it makes sense to look at the numbers firsthand and decide where you stand. To weigh the potential upside against the issues investors are flagging, start with 1 key reward and 3 important warning signs.

Looking for more investment ideas beyond Marqeta?

If Marqeta has sharpened your focus on risk and reward, you can use that momentum to scan for other stocks that match your goals before the next move in the market.

• Target potential mispricings by reviewing companies that screen well on value, quality, and fundamentals through the 43 high quality undervalued stocks
• Strengthen your core holdings by checking out companies with robust finances and balance sheets using the solid balance sheet and fundamentals stocks screener (48 results)
• Hunt for lesser known opportunities with strong fundamentals and room for attention to catch up by running the screener containing 19 high quality undiscovered gems

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.